ライフサイエンスコーパス: embolization

1 of 697 +/- 157 days (P < 0.001 versus before embolization).

2 events (pericardial effusion, stroke, device embolization).

3 e long-term safety and efficacy of bariatric embolization.

4 al loss in the left eye (LE) two hours after embolization.

5 important drawbacks of intracranial aneurysm embolization.

6 -related complications; one of them required embolization.

7 ogically visible PAVMs too small to treat by embolization.

8 It was successfully treated with coil embolization.

9 December 27, 2010, prior to uterine fibroid embolization.

10 I lesions were seen, but 2 animals had renal embolization.

11 arge SPSSs that were considered eligible for embolization.

12 he three patients had symptoms of ZES before embolization.

13 entified bleeding site as well as palliative embolization.

14 nomas were selected if treated with arterial embolization.

15 riable atheromatous debris to prevent distal embolization.

16 control animals, and were more sensitive to embolization.

17 lization for cancer; and 60, uterine fibroid embolization.

18 hemispheres in a pattern suggesting cerebral embolization.

19 was more effective, markedly decreasing clot embolization.

20 (p) hBF8 efficacy, including increased clot embolization.

21 e predictors of clinical deterioration after embolization.

22 al carotid artery (ICA) following small clot embolization.

23 in P(50) when given 1, but not 3 h following embolization.

24 attern and a major blush reduction following embolization.

25 perienced acute clinical deterioration after embolization.

26 ce (p=0.022) and volume (p=0.0001) following embolization.

27 .3 mg/kg, IV) was administered 1 h following embolization.

28 rgery, and analyze the outcomes of lymphatic embolization.

29 haemorrhage and show its usefulness prior to embolization.

30 ical excision, stereotactic radiosurgery and embolization.

31 cessfully managed with a stent-assisted coil embolization.

32 ymphatic intervention, including complete TD embolization.

33 to compare SNR measurements before and after embolization.

34 l anticoagulation strategies affect cerebral embolization.

35 Patients not eligible for ablation received embolization.

36 was achieved via sequential coronary artery embolizations.

37 There were no MitraClip device embolizations.

38 these leaks may preclude clinically relevant embolizations.

39 was achieved via sequential coronary artery embolizations.

40 death (16%), valve surgery (6%), late device embolization (0.4%), and new hemolysis requiring transfu

41 procedure-related strokes (0.078%); 9 device embolizations (0.24%) (6 requiring surgical removal); an

42 ents, and the main complications were device embolization (1.9%) and pericardial effusion (1.9%), wit

43 hort-term basis (i.e., within 100 days after embolization), 22 out of 37 patients (59.4%) were free o

44 y 104% and 181%; but not when given 3 h post-embolization (48% increase, p>0.05).

45 s with clinical stroke and subclinical brain embolization (62% versus 53%; P=NS) and was higher among

46 safety, and short-term efficacy of bariatric embolization, a recently developed endovascular procedur

47 Acute brain embolization (ABE) in left-sided infective endocarditis

48 etic resonance imaging and hypothesized that embolization acutely decreases SPC flow and increases sy

49 curative exclusion of AVM from circulation, embolization adjuvant to resection or radiation therapy,

50 Six months after embolization, all the 3 patients had a clinical and comp

51 behavioral outcome when given 2 h following embolization; an increase that is not affected by combin

52 ng, the incidence rates of subclinical brain embolization and any ABE were 48% and 80%, respectively.

53 8 consecutive patients with liver lymphatic embolization and congenital heart disease with elevated

54 rvention aims to decrease the rate of distal embolization and impaired myocardial reperfusion after p

55 Two strategies proposed to reduce distal embolization and improve outcomes after primary PCI are

56 and the presumed but not proven mechanism is embolization and occlusion of end arterioles.

57 ac myxomas, chemotherapy, radiotherapy, coil embolization and surgical treatment could be helpful.

58 clinical importance to estimate the risk for embolization and the necessity of anticoagulation.

59 The fistula was occluded with embolization and the patient showed recovery following t

60 on of glomus jugulare tumors with the use of embolization and the subtotal occlusion poses a high ris

61 tin was administered up to 3 hours following embolization, and behavior was measured 48 hours followi

62 ity, which has ramifications for the growth, embolization, and lysis of thrombi.

63 els: partial hepatectomy, portal ligature or embolization, and radiotherapy or chemotherapeutic drugs

64 vironmental conditions, may account for some embolization, and suggest a target for therapeutic inter

65 periority of chemoembolization compared with embolization, and the role of chemotherapy remains uncle

66 s resulted in loss of stent integrity, stent embolization, aortic wall injury, or reobstruction.

67 Percutaneous embolization appears to be the best method of treatment

68 In this study, the results of embolization are presented, and the literature results a

69 omplications (ARR -17.3%, P<0.001), systemic embolization (ARR -12.9%, P=0.002), S aureus NVE (ARR -2

70 ymphangiographic imaging and liver lymphatic embolization as a treatment for PLE.

71 ws commercially available materials used for embolization as well as polymeric materials that are und

72 An accurate pre-embolization assessment of bleeding with CT angiography

73 This facilitates angiographic monitoring of embolization at any stage.

74 l closure, no reflow, slow reflow, or distal embolization at any time during the procedure, occurred

75 CES (also referred to as cholesterol crystal embolization, atheromatous embolization or atheroembolis

76 nce of severe aortic regurgitation, abscess, embolization before surgical treatment, and transfer fro

77 ) by 143% when administered 1 hour following embolization but was ineffective at 3 hours.

78 perfusion of ICA can increase RCBF following embolization, but this is not associated with improved n

79 percutaneous puncture of pseudoaneurysm and embolization by coils.

80 ssessed with all modalities before and after embolization by using a qualitative three-point scale sc

81 and perfusion were measured before and after embolization by using velocity-encoded and perfusion MR

82 This is the first demonstration that embolization can decrease ATP content in rabbit cortex a

83 Bariatric embolization can significantly suppress ghrelin and sign

84 ion-induced behavior measured 24 h following embolization compared to control (P(50)=1.01+/-0.48 mg).

85 The best volumetric embolization conditions, which resulted in the regenerat

86 Embolization decreased cortical ATP content in ischemic

87 We report on the acute efficacy of SPC embolization, demonstrating a significant decrease in SP

88 arteriography performed with the purpose of embolization did not reveal the pseudoaneurysm.

89 may be more effective in preventing cerebral embolization during CAS than filters.

90 history of CAD are associated with increased embolization during CAS.

91 Thrombus embolization during percutaneous coronary intervention (

92 polymer mesh, was designed to reduce distal embolization during percutaneous coronary intervention i

93 prove TIMI flow pre-PCI and decreased distal embolization during procedure.

94 nted in all patients, with no cases of valve embolization, ectopic valve deployment, or additional va

95 respiratory distress syndrome from Lipiodol embolization following transarterial chemoembolization c

96 atively (with the assistance of angiographic embolization for 25 patients).

97 were no significant differences in cerebral embolization for bivalirudin versus heparin anticoagulat

98 er of gastrinoma patients treated with liver embolization for liver metastases were found, and simila

99 in hypertrophy response between the other 3 embolization groups.

100 The acute efficacy of SPC embolization has not been demonstrated in a quantifiable

101 Preoperative portal vein embolization has thus far been established as the standa

102 roaches using endovascular therapy with coil embolization have also been attempted with good results

103 ical examples of injury from (90)Y nontarget embolization have likely resulted from relatively large

104 transcatheter therapies such as portal vein embolization, hepatic artery infusion chemotherapy, tran

105 e importance of measures such as portal vein embolization, hepatic pedicle clamping and preservation

106 stage of the procedure, access, portal vein embolization, if used, types of transection and hepatect

107 Portal vein embolization improves the safety of liver resection by i

108 (0.65%), because of dysrhythmia in 2, device embolization in 1, and cardiac erosion in 3.

109 rformed in 55 aneurysms (83.3%), and partial embolization in 11 aneurysms (16.7%).

110 Procedural mortality was 3.6%, with TAV embolization in 2.2% and conversion to surgery in 2.2%.

111 present in 25 aneurysms (86.2%), and partial embolization in 4 aneurysms (13.8%), respectively.

112 respiratory distress syndrome from Lipiodol embolization in a patient who underwent transarterial ch

113 resonance imaging detected subclinical brain embolization in a substantial number of patients with le

114 gle ischemic insult) in 16 pigs and coronary embolization in eight of the 16 pigs (32 mm(3), 40-120 m

115 ion (HAL), which recapitulates transarterial embolization in mouse models, to enhance the efficacy of

116 This study documented cerebral embolization in nearly two-thirds of patients during con

117 Behavior was measured 24 h following embolization in order to calculate the effective stroke

118 be rescued with exogenous ADP and increased embolization in Stx8(-/-) mice in vivo consistent with a

119 receives warfarin for prevention of systemic embolization in the setting of hypertension, diabetes, a

120 , and severity of the worst HE episode after embolization in three-quarters of the patients.

121 terventional therapy (including endovascular embolization) in preventing death or stroke.

122 However, TNK treatment (2-hours post-embolization) in the absence or presence of REP (initiat

123 ple endovascular procedure (ie, renal artery embolization) in vivo and to compare with x-ray guidance

124 Methods for preventing off-target embolization, increasing the specificity of microsphere

125 REP (P(50)=1.18+/-0.43 mg) had no effect on embolization-induced behavior measured 24 h following em

126 ieve atherothrombotic debris and prevent its embolization into the microcirculation, but their effect

127 These therapies, which include transarterial embolization, intraarterial chemoinfusion, transarterial

128 Cerebral embolization is a frequent complication after transcathe

129 Selective liver embolization is an effective and safe therapy for the tr

130 Portal vein embolization is associated with increased TGR and new tu

131 Robust healing after coil embolization is associated with substantial biological a

132 Conclusion Bariatric embolization is feasible and appears to be well tolerate

133 PAVM occlusion by embolization is the standard of care to reduce these ris

134 Embolization is the treatment of choice in the case of s

135 In the cases of unresectable tumors embolization is used as a palliative procedure.

136 Embolization is used in treatment of spontaneous and tra

137 Portal vein embolization is used to increase future remnant liver vo

138 ncidence of ABE, including subclinical brain embolization, is unknown.

139 with chronic LBBB combined with infarction (embolization; LBBB plus myocardial infarction, and conce

140 Lymphatic embolization led to improved albumin levels and relief o

141 nd avoid the complications of splenic artery embolization like infarcts and abscess.

142 ieved regression of hepatic metastases after embolization lived much longer than did those who did no

143 Application of temporary, absorbable embolization materials could be advantageous in some sit

144 Except for polidocanol, none of the embolization materials exhibited evident hepatotoxicity.

145 pertrophy response than the use of permanent embolization materials.

146 We hypothesized that cerebral embolization may be reduced by anticoagulation with biva

147 to identify anatomic factors predisposing to embolization may help improve stroke prediction in patie

148 creasing the size of residual liver, but the embolization may increase tumor growth during the waitin

149 mean score, 14; 95% CI: 11, 18), and fibroid embolization (mean score, 12; 95% CI: 9, 15) patients.

150 e, 26; 95% CI: 22, 29; P < .001) and fibroid embolization (mean score, 24; 95% CI: 21, 27; P < .001).

151 fferent from those of women awaiting fibroid embolization (mean, 16; 95% CI: 14, 18; P = .23).

152 increase in PVR generated by acute pulmonary embolization (n = 10); 2) serial changes in PVR in chron

153 bnormal first rib (n = 3), and/or history of embolization (n = 2).

154 ervention) vs intervention (any endovascular embolization, neurosurgical excision, or stereotactic ra

155 width, sac-to-neck ratio, initial result of embolization, number of coils used and the use of hydrog

156 ower (5.6% versus 13.4%, P=0.07), and distal embolization occurred significantly less often in the am

157 ce interval,1.07-5.67) and valve dislodgment/embolization (odds ratio, 4.36; 95% CI, 1.21-15.69); new

158 was necessary and it resulted in a complete embolization of 5 aneurysms.

159 Cerebral embolization of air microbubbles or microparticulate deb

160 rdiac catheterization with coil and particle embolization of angiographically evident SPC vessels.

161 Embolization of bleeding vessel within the tumor was eff

162 Embolization of branches of the left gastric artery that

163 rvey of the literature made us conclude that embolization of cavernous artery by means of an autologo

164 ears to be a safe and efficient material for embolization of cerebral AVMs, also in cases of intracra

165 on (TAVI) due to dislodgement and subsequent embolization of debris from aortic arch atheroma or from

166 Preoperative embolization of graft SMA is a useful alternative to ass

167 rsity of Miami, of whom 6 patients underwent embolization of graft SMA seven times before graft enter

168 We report our experience in preoperative embolization of graft superior mesenteric artery (SMA) t

169 of patients with uveal melanoma who received embolization of hepatic metastases and possibly delayed

170 findings suggest that detachment and distal embolization of hydrophilic-coating material from corona

171 Distal embolization of hydrophilic-coating material was observe

172 equiring therapeutic surgery or angiographic embolization of injuries.

173 Embolization of kidney cancer in particular cases may be

174 efficacy and safety of patients treated with embolization of large SPSSs for the treatment of chronic

175 respiratory distress syndrome from pulmonary embolization of Lipiodol, an iodinated oil commonly used

176 Embolization of liver metastases might reduce symptoms o

177 latinum-containing systemic chemotherapy; 3) embolization of segments 5-8 versus 4-8; and 4) baseline

178 Curative embolization of small cerebral AVMs is an efficient and

179 We highlighted the use of pre-operative embolization of such a vascular rib lesion before surgic

180 mal model of PEI, steatorrhea was induced by embolization of the exocrine pancreas gland and pancreat

181 phthalmic artery occlusion after Embozene(R) embolization of the external carotid artery (ECA).

182 Transarterial embolization of the gastric fundus with fluoroscopic gui

183 This was followed by coil embolization of the HAA with improvement in symptoms and

184 The resultant embolization of the infected clot can contribute to the

185 nt sessions in most patients, with selective embolization of the left and right liver lobes within 6

186 Thus, selective radiological embolization of the left hepatic artery branches was nec

187 Our patient was treated by embolization of the lesion with 20% glue, after which he

188 He subsequently underwent embolization of the maxillary branch of the left ECA usi

189 The patient was successfully treated by embolization of the penile artery with an autologous clo

190 There is a recent focus on embolization of the portal vein by transplanted islets a

191 ing or retrieval of the valve prosthesis and embolization of the prosthesis; and other complications.

192 A selective embolization of the right hepatic artery was carried out

193 1 mixture of NBCA and lipiodol were used for embolization of the spermatic vein.

194 sed concerns about detachment and subsequent embolization of these hydrophilic coatings.

195 ubstantiated the effectiveness and safety of embolization of these shunts, provided there is sufficie

196 d, this could enhance thrombus formation and embolization of thrombi around the device into the circu

197 tent foramen ovale (PFO) may permit arterial embolization of thrombi that accumulate on the leads of

198 and evaluate a novel method of endovascular embolization of varicoceles using n-butyl cyanoacrylate

199 Embolization of varicoceles using NBCA glue is efficient

200 4%) were free of HE (P < 0.001 versus before embolization) of which 18 (48.6% of patients overall) re

201 e sought to assess the acute efficacy of SPC embolization on blood flow as quantified by phase contra

202 f shear rate, suggesting a potential risk of embolization on treatment with PI3Kbeta inhibitors.

203 were successfully treated with intravascular embolization; one patient underwent additional hemostati

204 olesterol crystal embolization, atheromatous embolization or atheroembolism) occurs when cholesterol

205 to increase cell engraftment based on portal embolization or irradiation of the liver are being asses

206 What is the likelihood of distal embolization or periprocedural myocardial infarction dur

207 icult to control; they often re-expand after embolization or resection, and pharmacologic therapy is

208 he treatment usually involves trans-arterial embolization or surgical resection.

209 edian Q(P):Q(S) from 1.3 before to 0.8 after embolization (P=0.03), and an increase in Q(S) from a me

210 predictors of outcome after prostate artery embolization (PAE) for benign prostatic hyperplasia with

211 atients, and 23 (95% CI: 18, 27) for fibroid embolization patients.

212 ation]; age range, 12-72 years) who had PAVM embolization, persistence by computed tomography (CT), a

213 This study refined the original embolization procedure using an automated, pump-assisted

214 ximum of 19 mm Hg (SD, 4.5 mm Hg) due to the embolization procedure.

215 were measured for MR-guided and x-ray-guided embolization procedures and are presented as means +/- s

216 Percutaneous transcatheter embolization procedures involve the selective occlusion

217 en of 18 patients underwent either lymphatic embolization procedures or thoracic duct stenting with c

218 p, tattoos, hairbands, clothes, endovascular embolization, prostheses, surgical clips, intraorbital a

219 l outcome of patients undergoing portal vein embolization (PVE) and autologous CD133 bone marrow-deri

220 the future liver remnant (FLR), portal vein embolization (PVE) of the tumor-bearing liver is used to

221 acute increases in PVR induced by pulmonary embolization (r = -0.92), serial PVR fluctuations in chr

222 Following embolization, RCBF was reduced to 48-55% of baseline.

223 TSC (0.25 mg/kg) given 5 or 60 min following embolization significantly (p<0.05) increased P(50) valu

224 ion, TSC plus tPA administered 3 h following embolization significantly (p<0.05) increased the group

225 or presence of REP (initiated 2 h following embolization) significantly (p<0.05) increased the group

226 r complications, valve perforation, systemic embolization, stroke, Staphylococcus aureus infection, a

227 To describe cholesterol embolization syndrome (CES) and its risk factors, pathop

228 Transarterial-chemo-embolization (TACE) is used for palliation of unresectab

229 Transarterial embolization (TAE) has been extensively used to manage u

230 radiopaque microspheres during transarterial embolization (TAE) in the VX2 rabbit liver tumor model b

231 which was followed by transcatheter arterial embolization (TAE) of the BAA and of the pathological br

232 s factors after bland transcatheter arterial embolization (TAE), a purely ischemic treatment for hepa

233 d to potentiate treatment with transarterial embolization (TAE).

234 surviving ischemia induced by transarterial embolization (TAE)/transarterial chemoembolization (TACE

235 The standard coil embolization technique is limited by its inability to oc

236 Three hours after embolization, the cerebral cortex was excised and proces

237 In patients with embolization, the warm ischemia time (from embolization

238 Paradoxical embolization then may link cardiac and extracardiac righ

239 may increase the possibility of paradoxical embolization through the PFO has made some progress and

240 and behavior was measured 48 hours following embolization to calculate the dose of emboli (P(50) in m

241 udy inclusion after surgical or angiographic embolization to control bleeding (D1), and then three ti

242 s and embolic agents since Duggan introduced embolization to management of postraumatic epistaxis in

243 h embolization, the warm ischemia time (from embolization to removal of the graft) was 6.9 (1.1) hr (

244 In (90)Y radioembolization, nontarget embolization to the stomach or small bowel can result in

245 andom assignment was stratified by number of embolizations to complete treatment, and assignments wer

246 for utilization of preoperative portal vein embolization, transjugular intrahepatic portosystemic sh

247 : Authors analyzed the efficacy of selective embolization treatment of haemorrhage in advanced head a

248 the first (TV-in-TV) or transcatheter valve embolization (TVE) after transcatheter aortic valve repl

249 s of study design, anticancer drug, RT type, embolization type, presence of portal venous tumor throm

250 nts, study design, anticancer drug, RT type, embolization type, presence of PVTT, and time between TA

251 e in the literature regarding uterine artery embolization (UAE).

252 (compared with myomectomy or uterine artery embolization [UAE]), but rates of more serious complicat

253 ter conventional and partial uterine fibroid embolization (UFE).

254 d with successful percutaneous transcatheter embolization under emergency conditions.

255 easible for renal artery catheterization and embolization under real-time MR imaging in vivo, and qua

256 shear rate, highlighting a potential risk of embolization upon PI3Kbeta inhibition.

257 his randomized trial compares the outcome of embolization using microspheres alone with chemoemboliza

258 umetric (distal, partial, and random) portal embolization (VPE), which preserves total liver volume.

259 serum creatinine in patients with or without embolization was 0.2 (0.05) versus 0.16 (0.04), respecti

260 The incidence of valve embolization was 0.3% (n=3), and coronary obstruction wa

261 Freedom from clip embolization was 100%.

262 n operation time in patients with or without embolization was 5.2 (1.2) versus 8.7 (1.3) hr, respecti

263 mated blood loss in patients with or without embolization was 600 (173) versus 1437 (328) mL, respect

264 In 160 patients, partial embolization was intentionally performed to preserve fer

265 In 6 aneurysms (9.1%), re-embolization was necessary and it resulted in a complete

266 Coil embolization was not possible due to the small caliber o

267 Bariatric embolization was performed by infusion of 40-mum calibra

268 Surgery or embolization was performed in 11 of the 22 patients with

269 Portal vein embolization was performed in 28 patients diagnosed with

270 A complete embolization was performed in 55 aneurysms (83.3%), and

271 Embolization was performed in the portal trunk of C57BL6

272 The successful embolization was performed to ultimately stop the bleedi

273 An ad hoc coil embolization was performed with angiographic success.

274 Transarterial embolization was planned but repeat cerebral angiography

275 On a follow-up DSA, complete embolization was present in 25 aneurysms (86.2%), and pa

276 Tumor embolization was proceeded as a minimally invasive proce

277 A marked increase in embolization was seen following FeCl3 injury in GPVI-def

278 Results Embolization was successful in all six kidneys under bot

279 Lymphatic embolization was successful in patients with traumatic l

280 Coil embolization was tried but the coil dislodged into the r

281 rforation with or without cardiac tamponade, embolization) was 0.33% for LVEMB and 0.45% for RVEMB, w

282 After embolization, we found a significant decrease in SPC flo

283 rotocol, in vivo renal artery navigation and embolization were tested in three farm pigs (mean weight

284 e balloon postdilation and valve dislodgment/embolization were the predictors of acute CVEs, new-onse

285 nsidered as an alternative to trans-arterial embolization when the pseudoaneurysm cannot be visualize

286 Six swine underwent bariatric embolization, while six control animals underwent a sham

287 matemesis, who was successfully treated with embolization with a 1:2 dilution of N-butyl cyanoacrylat

288 We examined whether experimental lung embolization with autologous blood clots or with the inf

289 Embolization with blood clots or microspheres increased

290 s also the therapeutic challenge of a failed embolization with consequent microcoil migration and pri

291 Liver lymphatic embolization with ethiodized oil in 2 patients resulted

292 Endovascular embolization with hydrogel coils is an effective and saf

293 patients with HCC were randomly assigned to embolization with microspheres alone (Bead Block [BB]) o

294 mptoms after resection of the varix, 2 after embolization with n-butyl cyanoacrylate and 2 via a righ

295 Of the remaining 6 patients, liver lymphatic embolization with n-butyl cyanoacrylate glue resulted in

296 t true aneurysm we performed an endovascular embolization with N-butyl-cyano-acrylate (NBCA) glue.

297 ent was discharged in good general condition Embolization with NBCA can be an efficient method to tre

298 usion of chemotherapeutic agents followed by embolization with particles.

299 recurrent, even after n-butyl cyanoacrylate embolization, with repeated Valsalva-type maneuvers.

300 it clinically silent lesions from procedural embolization, yet the main source and predominant proced